Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer - Contacts and Locations

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

This study has been completed.

Study NCT00004065. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004065

Locations


United States, California
	Jonsson Comprehensive Cancer Center, UCLA
	Los Angeles, California, United States, 90095

United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Howard I. Scher, MD	Memorial Sloan-Kettering Cancer Center